Loading...
•
Mar 31, 2021
Zoetis Q1 2021 Earnings Report
Reported revenue growth, increased net income, and raised full year revenue guidance.
Key Takeaways
Zoetis reported a strong start to 2021 with a 22% increase in revenue to $1.9 billion and a 32% increase in net income to $559 million, or $1.17 per diluted share. The company's adjusted net income increased by 33% to $603 million, or $1.26 per diluted share. Due to this strong performance, Zoetis increased its full year 2021 revenue guidance to $7.500 - $7.625 billion and diluted EPS of $4.08 - $4.19 on a reported basis, or $4.42 - $4.51 on an adjusted basis.
Revenue reached $1.9 billion, a 22% increase compared to Q1 2020.
Net income was $559 million, or $1.17 per diluted share, a 32% increase.
Adjusted net income was $603 million, or $1.26 per diluted share, a 33% increase.
Full year revenue guidance increased to $7.500 - $7.625 billion.
Zoetis
Zoetis
Zoetis Revenue by Segment
Zoetis Revenue by Geographic Location
Revenue by Segment
Companion Animal Revenue
CapyFin.comLivestock Revenue
CapyFin.comContract Mfg. & Human Health Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Zoetis is increasing its full year 2021 guidance, which includes revenue between $7.500 billion and $7.625 billion, reported diluted EPS between $4.08 and $4.19, and adjusted diluted EPS between $4.42 and $4.51.
Positive Outlook
- Revenue between $7.500 billion and $7.625 billion.
- Operational growth of 10.5% to 12%.
- Adjusted cost of sales as a percentage of revenue approximately 30%.
- Adjusted SG&A expenses between $1.820 billion and $1.870 billion.
- Adjusted R&D expenses between $500 million and $520 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income